Yoshie Itakura

Naturally occurring, resistance‐associated hepatitis C virus NS5A variants are linked to interleukin‐28B genotype and are sensitive to interferon‐based therapy

N. Enomoto, M. Kurosaki, N. Izumi, 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

Resistance-Associated NS5A Variants of Hepatitis C Virus Are Susceptible to Interferon-Based Therapy

N. Enomoto, M. Kurosaki, N. Izumi, 2015, PloS one.

Targeting lipid metabolism in the treatment of hepatitis C virus infection.

N. Enomoto, M. Sakamoto, N. Sakamoto, 2008, The Journal of infectious diseases.

Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup

M. Kurosaki, N. Izumi, H. Nakanishi, 2020, International journal of molecular sciences.

Inhibition of 17α-Hydroxylase/C17,20-Lyase (CYP17) from Rat Testis by Green Tea Catechins and Black Tea Theaflavins

M. Yoshihama, K. Kimura, Yoshie Itakura, 2007, Bioscience, biotechnology, and biochemistry.

Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response.

N. Enomoto, N. Sakamoto, M. Nakagawa, 2007, The Journal of general virology.

Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease

M. Kurosaki, N. Izumi, H. Nakanishi, 2021, Journal of gastroenterology and hepatology.

Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response.

N. Enomoto, N. Sakamoto, M. Nakagawa, 2007, The Journal of general virology.

Detecting advanced liver fibrosis using ultrasound shear wave velocity measurement in the general population

M. Kurosaki, N. Izumi, R. Okamoto, 2023, Quantitative imaging in medicine and surgery.